Catalyst Wire Dossier Catalyst Wire Dossier

CENV3 Vaccine

CENV3 · National Liver Institute, Egypt
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CENV3 Vaccine, covering 2012-10-31 to 2012-10-31. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of CENV3 Vaccine to Protect Against HCV Infection [Phase 1, Phase 2]

See pricing